Pure Biologics S.A. (WSE:PUR)
Poland · Delayed Price · Currency is PLN 2.090
-0.090 (-4.13%)
Jun 16, 2026, 4:11 PM CET
Pure Biologics Cash Flow Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -10.73 | -9.82 | -19.44 | -35.69 | -25.6 | -11.77 |
Depreciation & Amortization | 0.11 | 0.16 | 0.31 | 0.21 | 2.23 | 2.65 |
Other Amortization | - | - | - | - | 0.27 | 0.27 |
Loss (Gain) From Sale of Assets | -0.99 | -0.99 | - | 0.24 | 0.62 | 0.03 |
Other Operating Activities | 4.78 | 4.48 | 1.34 | 8.65 | 4.76 | 3.01 |
Change in Accounts Receivable | 1.02 | 0.69 | 12.98 | 0.2 | -5.93 | -7.94 |
Change in Unearned Revenue | - | - | -4.81 | 1.95 | -0.93 | -8.59 |
Change in Other Net Operating Assets | -0.78 | 1.23 | -0.9 | -6.65 | 7.19 | -1.71 |
Operating Cash Flow | -8.63 | -6.25 | -10.83 | -23.26 | -17.39 | -24.04 |
Capital Expenditures | - | - | - | -0.18 | -5.76 | -0.67 |
Sale of Property, Plant & Equipment | 0.05 | - | - | 4.93 | 0.05 | 0.01 |
Investment in Securities | - | - | - | -4 | 21.05 | -27.81 |
Other Investing Activities | 0.98 | 0.94 | 3.56 | -0.37 | - | - |
Investing Cash Flow | 1.04 | 0.94 | 3.56 | 0.39 | 15.35 | -28.48 |
Long-Term Debt Issued | - | - | 4.42 | 12 | - | - |
Total Debt Issued | - | - | 4.42 | 12 | - | - |
Long-Term Debt Repaid | - | -0.06 | -0.15 | -6.64 | -1.55 | -2.15 |
Total Debt Repaid | -0.03 | -0.06 | -0.15 | -6.64 | -1.55 | -2.15 |
Net Debt Issued (Repaid) | -0.03 | -0.06 | 4.27 | 5.36 | -1.55 | -2.15 |
Issuance of Common Stock | 8.16 | 5.09 | - | 18.86 | - | 52.11 |
Other Financing Activities | 0.27 | -0.03 | -0.29 | - | -0.33 | -0.23 |
Financing Cash Flow | 8.39 | 5.01 | 3.98 | 24.22 | -1.88 | 49.74 |
Miscellaneous Cash Flow Adjustments | -0 | -0 | - | -0 | - | - |
Net Cash Flow | 0.79 | -0.3 | -3.29 | 1.35 | -3.92 | -2.78 |
Free Cash Flow | -8.63 | -6.25 | -10.83 | -23.44 | -23.15 | -24.71 |
Free Cash Flow Margin | - | - | - | - | -3496.22% | -9727.56% |
Free Cash Flow Per Share | -1.20 | -1.27 | -3.11 | -7.35 | -10.27 | -11.12 |
Cash Interest Paid | 0.03 | 0.03 | 0.07 | - | 0.33 | 0.23 |
Levered Free Cash Flow | -4.2 | -6.12 | 1.43 | -10.05 | -14.08 | -19.85 |
Unlevered Free Cash Flow | -2.61 | -4.76 | 2.26 | -9.51 | -13.88 | -19.71 |
Change in Working Capital | 0.24 | 1.91 | 7.27 | -4.5 | 0.33 | -18.24 |